Vybrané publikácie
Vybrané publikácie pracovníkov Neurologickej kliniky JLF UK a UN v Martine
1. Drobný M., Sániová B., Michalik J., Luliak M., Kurča E., Švaleková A.: Practices of Stroke Care and Rehabilitation in Turiec Region. Journal of health management and public health, 1999, Vol 4, No 3-4, s. 38-46.
2. Kurča E., Drobný M.: Four quantitative EMG methods and theirs individual parameter diagnostic value. Electromyography and Clinical Neurophysiology, 2000, No 8, Vol 40, s. 451–458.
3. Drobný M., Kurča E.: Possible extrapyramidal system degradation in Parkinson¢s disease. Brain Research Bulletin, 2000, No 4, Vol 53, s. 425-430.
4. Kurča E., Drobný M., Voško M.R., Nosáľ V., Goldman A.M., Straková J., Grofik M.: Unique case of eleven Bell¢s palsy episodes. International Journal of Neuroscience, 2001, 111, s. 55-65.
5. Kurča E., Kadaňka Z., Drobný M., Nosáľ V., Grofik M.: Antineuronal antibody testing in an unusual case of recurrent Bell's palsy. Acta Clinica Croatica, 2002, 41, s. 263-267.
6. Drobný M., Voško M.R., Kurča E., Mitrová E., Piťhová B., Trstenský D., Adamková M., Šútorová D., Mlynárik V., Dobrota D.: Prolonged Course of Creutzfeldt-Jakob Disease with Excessive CNS Degeneration. Acta Clinica Croatica, 2004, 1, s. 33-38.
7. Kurča E., Grofik M., Kučera P., Varsik P.: Familial Occurrence of Adrenocortical Insufficiency in Two Brothers with Allgrove Syndrome. A Case Report of 4A (Allgrove) Syndrome with Epilepsy and a new AAAS Gene Mutation. Neuroendocrinological Letters, 2005, 26(5), s. 499-502.
8. Kurča E., Sivák Š., Kučera P.: Impaired cognitive functions in mild traumatic brain injury patients with normal and pathologic magnetic resonance imaging. Neuroradiology, 2006, 48, s. 661-669.
9. Šaňák D., Nosáľ V., Horák D., Bártková A., Zeleňák K., Herzig R., Bučil J., Školoudík D., Buřval S., Cisáriková V., Vlachová I., Köcher M., Zapletalová J., Kurča E., Kaňovský P.: Impact of initial cerebral infarction volume measured in diffusion-weighted MRI on clinical outcome in acute stroke patients with middle cerebral artery occlusion treated by thrombolysis. Neuroradiology, 2006, 48, s. 632-639.
10. Lees KR, Zivin JA, Ashwood T, Davalos A, Davis SM, Diener H-C, Grotta J, Lyden P, Shualb A, Hardemark H-G, Waslewski W for the Stroke-Acute Ischemic NXY Treatment (SAINT I) Trial Investigators (Kurča E). NXY-059 for Acute Ischemic Stroke. New England Journal of Medicine, 2006, 35, s. 588-600.
11. Sivák Š., Kurča E., Hladká M., Zeleňák K., Turčanová-Koprušáková M., Michalik J. Early and delayed auditory oddball ERP and brain MRI in patients with MTBI. Brain Injury, 2008, 22(2), s. 193-197.
12. Garren H., Robinson W.H., Krasulová E., Havrdová E., Nadj C., Selmaj K., Losy J., Nadj I., Radue E.W., Kidd B.A., Gianettoni J., Tersini K., Utz P.J., Valone F., Steinman L., BHT-3009 Study Group (Kurča E.). Phase 2 trial of a DNA vaccine encoding myelin basic protein for multiple sclerosis. Annals of Neurology, 2008, 63(5), s. 611-620.
13. Hacke W., Kaste M., Bluhmki E., Brozman M., Dávalos A., Guidetti D., Larrue V., Lees K.R., Medeghri Z., Machnig T., Schneider D., von Kummer R., Wahlgren N., Toni D., ECASS Investigators (Kurča E.). Thrombolysis with alteplase 3 to 4.5 hours after acute ischemic stroke. New England Journal of Medicine, 2008, 359(13), 1317-1329.
14. Bousser M.G., Amarenco P., Chamorro A., Fisher M., Ford I., Fox K., Hennerici M.G., Mattle H.P., Rothwell P.M., PERFORM Study Investigators (Kurča E.). Rationale and design of a randomized, double blind, parallel group study of Terutroban 30 mg/day versus Aspirin 100 mg/day in stroke patients: the prevention of cerebrovascular and cardiovascular events of ischemic origin with Terutroban in patients with a history of ischemic stroke or transient ischemic attack (PERFORM) study. Cerebrovascular Diseases 2009, 27(5), 509-518.
15. Sivák Š., Bittšanský M., Kurča E., Turčanová-Koprušáková M., Grofik M., Nosáľ V., Poláček H., Dobrota D. Proton magnetic resonance spectroscopy in patients with early stages of amyotrophic lateral sclerosis. Neuroradiology 2010, 52(12), 1079-1085.
16. Kappos L., Radue E.W., O´Connor P., Polman C., Hohlfeld R., Calabresi P., Selmaj K., Agoropoulou C., Leyk M., Zhang-Auberson L., Burtin P., FREEDOMS Study Group (Kurča E.). A placebo-controlled trial of oral fingolimod in relapsing multiple sclerosis. New England Journal of Medicine 2010, 362(5), 387-401.
17. Lees K.R., Bluhmki E., von Kummer R., Brott T.G., Toni D., Grotta J.C., Albers G.W., Kaste M., Marler J.M., Hamilton S.A., Tilley B.C., Davis S.M., Donnan G.A., Hacke W., ECASS (Kurča E.), ATLANTIS, NINDS and EPITHET rt-PA Study Group, Allen K., Mau J., Meier D., del Zoppo G., De Silva D.A., Butcher K.S., Parsons M.W., Barber P.A., Levi C., Bladin C., Byrnes G. Time to treatment with intravenous alteplase and outcome in stroke: an updated and pooled analysis of ECASS, ATLANTIS, NINDS and EPITHET trials. Lancet 2010, 375(9727), 1695-1703.
18. Zeleňák K., Zeleňáková J., DeRiggo J., Kurča E., Boudný J., Poláček H. Flow changes after endovascular treatment of a wide-neck anterior communicating artery aneurysm by using X-configured kissing stents (cross-kissing stents) technique. Cardiovascular Interventional Radiology, 2011, 34(6), s. 1308-1311.
19. Bousser M.G., Amarenco P., Chamorro A., Fisher M., Ford I., Fox K.M., Hennerici M.G., Mattle H.P., Rothwell P.M., de Cordoüe A., Fratacci M.D.; PERFORM (Kurča E.) study investigators. Lancet, 2011, 377(9782), s. 2013-2022.
20. Kantorová E., Chomová M., Kurča E., Sivák Š., Zeleňák K., Kučera P., Galajda P.: Leptin, adiponectin and ghrelin, new potential mediators of ischemic stroke. Neuroendocrinology Letters, 2011, 32(5), s. 716-721.
21. Devonshire V., Havrdova E., Radue E.W., O'Connor P., Zhang-Auberson L., Agoropoulou C., Häring D.A., Francis G., Kappos L.: Relapse and disability outcomes in patients with multiple sclerosis treated with fingolimod; subgroup analyses of the double-blind, randomised, placebo-controlled FREEDOMS (Kurča E.) study. Lancet Neurology, 2012, 11(5), s. 420-428.
22. Gold R, Kappos L, Arnold DL, Bar-Or A, Giovannoni G, Selmaj K, Tornatore C, Sweetser MT, Yang M, Sheikh SI, Dawson KT; DEFINE Study Investigators (Kurča E.). Placebo-controlled phase 3 study of oral BG-12 for relapsing multiple sclerosis. New England Journal of Medicine, 2012, 367(12), s. 1098-1107.
23. Fox RJ, Miller DH, Phillips JT, Hutchinson M, Havrdova E, Kita M, Yang M, Raghupathi K, Novas M, Sweetser MT, Viglietta V, Dawson KT; CONFIRM Study Investigators (Kurča E.). Placebo-controlled phase 3 study of oral BG-12 or glatiramer in multiple sclerosis. New England Journal of Medicine 2012, 367(12), s. 1087-1097.
24. Radue EW, O'Connor P, Polman CH, Hohlfeld R, Calabresi P, Selmaj K, Mueller-Lenke N, Agoropoulou C, Holdbrook F, de Vera A, Zhang-Auberson L, Francis G, Burtin P, Kappos L; FTY720 Research Evaluating Effects of Daily Oral Therapy in Multiple Sclerosis (FREEDOMS) (Kurča E.) Study Group. Impact of fingolimod therapy on magnetic resonance imaging outcomes in patients with multiple sclerosis. Arch Neurol 2012, 69(10), s. 1259-1269.
25. Fazekas F, Berger T, Fabjan TH, Ledinek AH, Jakab G, Komoly S, Kraus J, Kurča E, Kyriakides T, Lisý L, Milanov I, Panayiotou P, Jazbec SS, Taláb R, Traykov L, Turčáni P, Vass K, Vella N, Havrdová E. Fingolimod in the treatment algorithm of relapsing remitting multiple sclerosis: a statement of the Central and East European (CEE) MS Expert Group. Wien Med Wochenschr. 2012 Aug;162(15-16):354-66.
26. Zeleňák K., Zeleňáková J., DeRiggo J., Kurča E., Kantorová E., Poláček H.: Treatment of cervical internal carotid artery spontaneous dissection with pseudoaneurysm and unilateral lower cranial nerves palsy by two silk flow diverters. Cardiovascular and Interventional Radiology, 2013, 36, s. 1147-1150.
27. Lizrova Preiningerova J,Baumhackl U, Csepany T, Czaplinski A, Deisenhammer F, Derfuss T, Fabjan TH, Fazekas F, Fuchs S, Havrdova E, Horvath Ledinek A, Illes Z, Sega Jazbec S, Klimova E, Komoly S, Kurca E, Linnebank M, Lisy L, Mares J, Prochazkova L, Csilla R, Szilasiova J, Stourac P, Talab R, Turcani P, Vachova M, Vecsei L, Vodusek D, Zapletalova O, Berger T: Recommendations for the use of prolonged-release fampridine in patients with multiple sclerosis (MS). CNS Neuroscience & Therapeutics, 2013, 5(19), s. 302-306.
28. Zeleňák K, Nosáľ V, Zeleňáková J, Kurča E, Šinák I, Sivák Š, Poláček H: CAS-complications rate and relation to risk factors. Open Journal of Radiology, 2013, 1(3), s. 26-32.
29. Fazekas F, Bajenaru O, Berger T, Hojs Fabjan T, Horvat Ledinek A, Jakab G, Komoly S, Kobys T, Kraus J, Kurča E, Kyriakides T, Lisý Ľ, Milanov I, Nehrych T, Moskovko S, Panayiotou P, Šega Jazbec S, Sokolova L, Taláb R, Traykov L, Turčáni P, Vass K, Vella N, Voloshyná N, Havrdová E: How does fingolimod (Gilenya®) fit in the treatment algorithm for highly active relapsing-remitting multiple sclerosis? Frontiers in Neurology, 2013, 4, s. 1-14.
30. Sivák Š, Bittšanský M, Grossmann J, Nosál' V, Kantorová E, Siváková J, Demková A, Hnilicová P, Dobrota D, Kurča E. Clinical correlations of proton magnetic resonance spectroscopy findings in acute phase after mild traumatic brain injury. Brain Inj. 2014;28(3):341-6.
31. Confavreux C, O'Connor P, Comi G, Freedman MS, Miller AE, Olsson TP, Wolinsky JS, Bagulho T, Delhay JL, Dukovic D, Truffinet P, Kappos L; TOWER Trial Group (Kurca E). Oral teriflunomide for patients with relapsing multiple sclerosis (TOWER): a randomised, double-blind, placebo-controlled, phase 3 trial. Lancet Neurol. 2014 Mar;13(3):247-56.
32. Kantorová E, Žiak P, Kurča E, Koyšová M, Hladká M, Zeleňák K, Michalik J. Visual Evoked Potential and Magnetic Resonance Imaging are More Effective Markers of Multiple Sclerosis Progression than Laser Polarimetry with Variable Corneal Compensation. Front Hum Neurosci. 2014 Jan 22;8:10, 1-6.
33. Čierny D, Michalik J, Kurča E, Dobrota D, Lehotský J. FokI vitamin D receptor gene polymorphism in association with multiple sclerosis risk and disability progression in Slovaks. Neurol Res. 2015 Apr;37(4):301-8.
34. Miller DH, Fox RJ, Phillips JT, Hutchinson M, Havrdova E, Kita M, Wheeler-Kingshott CA, Tozer DJ, MacManus DG, Yousry TA, Goodsell M, Yang M, Zhang R, Viglietta V, Dawson KT; For the CONFIRM study investigators (Kurca E). Effects of delayed-release dimethyl fumarate on MRI measures in the phase 3 CONFIRM study. Neurology. 2015 Feb 13. pii: 10.1212/WNL.0000000000001360. [Epub ahead of print]
35. Kantorová E, Jesenská Ľ, Čierny D, Zeleňák K, Sivák Š, Stančík M, Galajda P, Nosáľ V, Kurča E. The Intricate Network of Adipokines and Stroke. Int J Endocrinol. Epub 2015 Dec 10.
36. Petrovičová A, Kurča E, Brozman M, Hasilla J, Vahala P, Blaško P, Andrášová A, Hatala R, Urban L, Sivák Š. Detection of occult paroxysmal atrial fibrilation by implantable long-term electrocardiographic monitoring in cryptogenic stroke and transient ischemic attack population: a study protocol for prospective matched cohort study. BMC Cardiovasc Disord. 2015; 15: 160. doi: 10.1186/s12872-015-0160-8.
37. Kantorová E, Marcinek J, Zeleňák K, Kantor K, Michalik J, Sivák Š, Kurča E, Plank L. Tumefactive demyelination of the spinal cord: a case report. Spinal Cord. 2015; 53: 877-80.
38. Čierny D, Hányšová S, Michalik J, Kantorová E, Kurča E, Škereňová M, Lehotský J. Genetic variants in interleukin 7 receptor α chain (IL-7Ra) are associated with multiple sclerosis risk and disability progression in Central European Slovak population. J Neuroimmunol. 2015; 282: 80-4.
39. Michalik J, Čierny D, Kantorová E, Kantárová D, Juraj J, Párnická Z, Kurča E, Dobrota D, Lehotský J. The association of HLA-DRB1 and HLA-DQB1 alleles with genetic susceptibility to multiple sclerosis in the Slovak population. Neurol Res. 2015;37(12):1060-7. doi: 10.1080/01616412.2015.1115212. Epub 2016 Jan 8.
40. Sivak S, Nosal V, Bittsansky M, Dluha J, Dobrota D, Kurca E. Type and occurrence of serious complications in patients after mild traumatic brain injury. Bratisl Lek Listy. 2016;117(1):22-5.
41. Sivák Š, Kantorová E, Kurča E, Marcinek J, Slávik P, Michalik J, Nosáľ V. Primary diffuse leptomeningeal gliomatosis as a rare cause of pain in cervical spine. BMC Cancer. 2016 Mar 4;16:182. doi: 10.1186/s12885-016-2224-2.
42. Cibulcik F, Benetin J, Kurca E, Grofik M, Dvorak M, Richter D, Donath V, Kothaj J, Minar M, Valkovic P. Effects of rasagiline on freezing of gait in Parkinson's disease - an open-label, multicenter study. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2016 Apr 21. doi: 10.5507/bp.2016.023. [Epub ahead of print]
43. Johnston SC, Amarenco P, Albers GW, Denison H, Easton JD, Evans SR, Held P, Jonasson J, Minematsu K, Molina CA, Wang Y, Wong KS; SOCRATES Steering Committee and Investigators (Kurča E). Ticagrelor versus Aspirin in Acute Stroke or Transient Ischemic Attack. N Engl J Med. 2016 Jul 7;375(1):35-43. doi: 10.1056/NEJMoa1603060. Epub 2016 May 10.
44. Čierny D, Michalik J, Škereňová M, Kantorová E, Sivák Š, Javor J, Kurča E, Dobrota D, Lehotský J. ApaI, BsmI and TaqI VDR gene polymorphisms in association with multiple sclerosis in Slovaks. Neurol Res. 2016 Aug;38(8):678-84. doi: 10.1080/01616412.2016.1200287. Epub 2016 Jun 23.
45. Validation of the Official Slovak Version of the Unified Dyskinesia Rating Scale (UDysRS). Skorvanek M, Minar M, Grofik M, Kracunova K, Han V, Cibulcik F, Necpal J, Gurcik L, Valkovic P. Parkinsons Dis. 2015; 2015:674796.
46. Relationship between the non-motor items of the MDS-UPDRS and Quality of Life in patients with Parkinson's disease. Skorvanek M, Rosenberger J, Minar M, Grofik M, Han V, Groothoff JW, Valkovic P, Gdovinova Z, van Dijk JP. J Neurol Sci. 2015; 353(1-2):87-91.
47. The safety and efficacy of Heparin and Nadroparin compared to placebo in acute ischemic stroke - pilot study. Dluha J, Sivak S, Kurca E, Dusenka R, Kalmarova K, Turcanova Koprusakova M, Kantorova E, Nosal V. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2016; 160(4):543-548.
48. Quantitative evaluation of cerebral white matter in patients with multiple sclerosis using multicomponent T2 mapping. Baranovicova E, Mlynarik V, Kantorova E, Hnilicova P, Dobrota D. Neurol Res. 2016; 38(5):389-96.
49. Therapeutical strategies for anxiety and anxiety-like disorders using plant-derived natural compounds and plant extracts. Fedotova J, Kubatka P, Büsselberg D, Shleikin AG, Caprnda M, Dragasek J, Rodrigo L, Pohanka M, Gasparova I, Nosal V, Opatrilova R, Qaradakhi T, Zulli A, Kruzliak P. Biomed Pharmacother. 2017; 95:437-446.
50. Some quantitative EEG features in default mode resting state network under general anaesthesia. Jombík P, Drobny M, Saniova B, Fischer M, Kaderjaková P, Lajčiaková M, Bakosova E, Drobna E, Bob P, Nosáľ V. Neuro Endocrinol Lett. 2017; 38(4):261-268.
51. SONOlysis in prevention of Brain InfaRctions During Internal carotid Endarterectomy (SONOBIRDIE) trial - study protocol for a randomized controlled trial. Hrbáč T, Netuka D, Beneš V, Nosáľ V, Kešnerová P, Tomek A, Fadrná T, Beneš V Jr, Fiedler J, Přibáň V, Brozman M, Langová K, Herzig R, Školoudík D. Trials. 2017; 18(1):25.
52. Perspectives and challenges of antioxidant therapy for atrial fibrillation. Gasparova I, Kubatka P, Opatrilova R, Caprnda M, Filipova S, Rodrigo L, Malan L, Mozos I, Rabajdova M, Nosal V, Kobyliak N, Valentova V, Petrovic D, Adamek M, Kruzliak P. Naunyn Schmiedebergs Arch Pharmacol. 2017; 390(1):1-14.
53. Differences in MDS-UPDRS Scores Based on Hoehn and Yahr Stage and Disease Duration. Skorvanek M, Martinez-Martin P, Kovacs N, Rodriguez-Violante M, Corvol JC, Taba P, Seppi K, Levin O, Schrag A, Foltynie T, Alvarez-Sanchez M, Arakaki T, Aschermann Z, Aviles-Olmos I, Benchetrit E, Benoit C, Bergareche-Yarza A, Cervantes-Arriaga A, Chade A, Cormier F, Datieva V, Gallagher DA, Garretto N, Gdovinova Z, Gershanik O, Grofik M, Han V, Huang J, Kadastik-Eerme L, Kurtis MM, Mangone G, Martinez-Castrillo JC, Mendoza-Rodriguez A, Minar M, Moore HP, Muldmaa M, Mueller C, Pinter B, Poewe W, Rallmann K, Reiter E, Rodriguez-Blazquez C, Singer C, Tilley BC, Valkovic P, Goetz CG, Stebbins GT. Mov Disord Clin Pract. 2017; 4(4):536-544.
54. Risk for Major Bleeding in Patients Receiving Ticagrelor Compared With Aspirin After Transient Ischemic Attack or Acute Ischemic Stroke in the SOCRATES Study (Acute Stroke or Transient Ischemic Attack Treated With Aspirin or Ticagrelor and Patient Outcomes). Easton JD, Aunes M, Albers GW, Amarenco P, Bokelund-Singh S, Denison H, Evans SR, Held P, Jahreskog M, Jonasson J, Minematsu K, Molina CA, Wang Y, Wong KSL, Johnston SC; SOCRATES Steering Committee and Investigators (Kurča E). Circulation. 2017; 136(10):907-916.
55. The role of vaspin as a predictor of coronary angiography result in SCAD (stable coronary artery disease) patients. Stančík M, Ságová I, Kantorová E, Mokáň M. BMC Cardiovasc Disord. 2017; 17(1):117.
56. Proton MR spectroscopic imaging of human glioblastomas at 1.5 Tesla. Hnilicová P, Richterová R, Kantorová E, Bittšanský M, Baranovičová E, Dobrota D. Gen Physiol Biophys. 2017; 36(5):531-537.
57. Thalamic paramagnetic iron by T2* relaxometry correlates with severity of multiple sclerosis. Baranovicova E, Kantorova E, Kalenska D, Lichardusova L, Bittsan-Sky M, Dobrota D. J Biomed Res. 2017; 31(4):301-305.
58. Cytokine and chemokine profile changes in patients with lower segment lumbar degenerative spondylolisthesis. Sutovsky J, Benco M, Sutovska M, Kocmalova M, Pappova L, Miklusica J, Frano A, Kurca E. Int J Surg. 2017; 43:163-170.
60. Kantorová E, Bittšanský M, Sivák Š, Baranovičová E, Hnilicová P, Nosáľ V, Čierny D, Zeleňák K, Brück W, Kurča E. BMC Cancer. 2017; 17(1):424.
61. Novel missense variant of CACNA1A gene: A case report of a family with episodic ataxia type 2. Sivák Š, Kurča E, Krajčiová A, Hikkelová M, Šimko J, Mišovicová N, Kantorová E, Turčanová-Koprušáková M, Burjanivová T, Čierny D, Nosál' V. J Neurol Sci. 2017; 376:119-120.
62. Hypothalamic damage in multiple sclerosis correlates with disease activity, disability, depression, and fatigue. Kantorová E, Poláček H, Bittšanský M, Baranovičová E, Hnilicová P, Čierny D, Sivák Š, Nosáľ V, Zeleňák K, Kurča E. Neurol Res. 2017; 39(4):323-330.
63. Novel missense variant of CACNA1A gene in a Slovak family with episodic ataxia type 2. Petrovicova A, Brozman M, Kurca E, Gobo T, Dluha J, Kalmarova K, Nosal V, Hikkelova M, Krajciova A, Burjanivova T, Sivak S. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2017; 161(1):107-110.
64. The age at onset in Multiple Sclerosis is associated with patient's prognosis. Cierny D, Lehotsky J, Hanysova S, Michalik J, Kantorova E, Sivak S, Kurca E, Dobrota D, Jesenska L. Bratisl Lek Listy. 2017; 118(6):374-377.
65. The influence of levodopa, entacapone and homocysteine on prevalence of polyneuropathy in patients with Parkinson's disease. Grofik M, Sivák Š, Nosáľ V, Turčanová Koprušáková M, Michalik J, Čierny D, Tatarková Z, Kurča E. J Neurol Sci. 2018; 392:28-31.
66. The HLA-DRB1 and HLA-DQB1 alleles are associated with multiple sclerosis disability progression in Slovak population. Čierny D, Lehotský J, Kantorová E, Sivák Š, Javor J, Kurča E, Dobrota D, Michalik J. Neurol Res. 2018; 40(7):607-614.
67. Siponimod versus placebo in secondary progressive multiple sclerosis (EXPAND): a double-blind, randomised, phase 3 study. Kappos L, Bar-Or A, Cree BAC, Fox RJ, Giovannoni G, Gold R, Vermersch P, Arnold DL, Arnould S, Scherz T, Wolf C, Wallström E, Dahlke F; EXPAND Clinical Investigators (Kurča E). Lancet. 2018; 391(10127):1263-1273.
68. Bilateral subthalamic deep brain stimulation initial impact on nonmotor and motor symptoms in Parkinson's disease: An open prospective single institution study. Kurcova S, Bardon J, Vastik M, Vecerkova M, Frolova M, Hvizdosova L, Nevrly M, Mensikova K, Otruba P, Krahulik D, Kurca E, Sivak S, Zapletalova J, Kanovsky P. Medicine (Baltimore). 2018; 97(5):e9750.
69. Relationship between the MDS-UPDRS and Quality of Life: A large multicenter study of 3206 patients. Skorvanek M, Martinez-Martin P, Kovacs N, Zezula I, Rodriguez-Violante M, Corvol JC, Taba P, Seppi K, Levin O, Schrag A, Aviles-Olmos I, Alvarez-Sanchez M, Arakaki T, Aschermann Z, Benchetrit E, Benoit C, Bergareche-Yarza A, Cervantes-Arriaga A, Chade A, Cormier F, Datieva V, Gallagher DA, Garretto N, Gdovinova Z, Gershanik O, Grofik M, Han V, Kadastik-Eerme L, Kurtis MM, Mangone G, Martinez-Castrillo JC, Mendoza-Rodriguez A, Minar M, Moore HP, Muldmaa M, Mueller C, Pinter B, Poewe W, Rallmann K, Reiter E, Rodriguez-Blazquez C, Singer C, Valkovic P, Goetz CG, Stebbins GT. Parkinsonism Relat Disord. 2018; 52:83-89.
70. Transplantation of Human-Induced Pluripotent Stem Cell-Derived Neural Precursors into Early-Stage Zebrafish Embryos. Strnadel J, Wang H, Carromeu C, Miyanohara A, Fujimura K, Blahovcova E, Nosal V, Skovierova H, Klemke R, Halasova E. J Mol Neurosci. 2018; 65(3):351-358.
71. Adipokines in neurovascular diseases. Opatrilova R, Caprnda M, Kubatka P, Valentova V, Uramova S, Nosal V, Gaspar L, Zachar L, Mozos I, Petrovic D, Dragasek J, Filipova S, Büsselberg D, Zulli A, Rodrigo L, Kruzliak P, Krasnik V. Biomed Pharmacother. 2018; 98:424-432.
72. [Unusual history of Wilson disease: a case report and review of the literature]. Nehaj F, Kubašková M, Mokáň M, Sokol J, Nosáľ V, Zeleňák K, Mokáň M. Vnitr Lek. 2018; 63(12):980-986.
73. Altered hypothalamic metabolism in early multiple sclerosis - MR spectroscopy study. Hnilicová P, Kantorová E, Poláček H, Grendár M, Bittšanský M, Čierny D, Sivák Š, Zeleňák K, Lehotský J, Dobrota D, Kurča E. J Neurol Sci. 2019; 407:116458.
74. Paramyotonia congenita in a Slovak population: Genetic and pedigree analysis of 3 families. Cibulcik F, Spalek P, Martinka I, Zidkova J, Grofik M, Sivak S, Kurca E. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2019; 163(4):362-365.
75. The contribution of cerebrovascular risk factors, metabolic and inflammatory changes to cognitive decline in Parkinson's disease: preliminary observations. Veselý B, Koriťáková E, Bohnen NI, Viszlayová D, Királová S, Valkovič P, Kurča E, Rektor I. J Neural Transm (Vienna). 2019; 126(10):1303-1312.
76. SNPs rs11240569, rs708727, and rs823156 in SLC41A1 Do Not Discriminate Between Slovak Patients with Idiopathic Parkinson's Disease and Healthy Controls: Statistics and Machine-Learning Evidence. Cibulka M, Brodnanova M, Grendar M, Grofik M, Kurca E, Pilchova I, Osina O, Tatarkova Z, Dobrota D, Kolisek M. Int J Mol Sci. 2019; 20(19):4688.
77. Adherence to Pharmacotherapy in Patients With Parkinson's Disease Taking Three and More Daily Doses of Medication. Straka I, Minár M, Škorvánek M, Grofik M, Danterová K, Benetin J, Kurča E, Gažová A, Boleková V, Wyman-Chick KA, Kyselovič J, Valkovič P. Front Neurol. 2019; 10:799.
78. The association of rs703842 variants in CYP27B1 with multiple sclerosis susceptibility is influenced by the HLA-DRB1*15:01 allele in Slovaks. Čierny D, Michalik J, Dubovan P, Škereňová M, Javor J, Kurča E, Dobrota D, Lehotský J. J Neuroimmunol. 2019; 330:123-129.
79. Increased glutamate and deep brain atrophy can predict the severity of multiple sclerosis. Polacek H, Kantorova E, Hnilicova P, Grendar M, Zelenak K, Kurca E. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2019; 163(1):45-53.
80. A case of relapsing isolated neurosarcoidosis in an 18-year-old male patient successfully treated by corticosteroids. Kalmárová K, Kurča E, Sivák Š, Michalik J, Plank L, Vyšehradský R, Zeleňák K, Šutovský J, Nosáľ V. Sarcoidosis Vasc Diffuse Lung Dis. 2019;36(1):79-85.
81. Induced Pluripotency: A Powerful Tool for In Vitro Modeling. Zahumenska R, Nosal V, Smolar M, Okajcekova T, Skovierova H, Strnadel J, Halasova E. Int J Mol Sci. 2020; 21(23):8910.
82. Generation of ORIONi001-A induced pluripotent stem cell line for in vitro modeling of sporadic form of amyotrophic lateral sclerosis. Strnadel J, Zahumenska R, Nosal V, Smolar M, Marcinek J, Kalman M, Juhas S, Juhasova J, Studenovska H, Dumortier H, Chromec T, Skovierova H, Mitruskova B, Kapralik I, Mersakova S, Brany D, Halasova E. Stem Cell Res. 2020; 48:101981.
83. Ticagrelor Added to Aspirin in Acute Nonsevere Ischemic Stroke or Transient Ischemic Attack of Atherosclerotic Origin. Amarenco P, Denison H, Evans SR, Himmelmann A, James S, Knutsson M, Ladenvall P, Molina CA, Wang Y, Johnston SC; THALES Steering Committee and Investigators (Kurča E). Stroke. 2020; 51(12):3504-3513.
84. Expanding the phenotype spectrum associated with pathogenic variants in the COL2A1 and COL11A1 genes. Čopíková J, Paděrová J, Románková V, Havlovicová M, Balaščáková M, Zelinová M, Vejvalková Š, Simandlová M, Štěpánková J, Hořínová V, Kantorová E, Křečková G, Pospíšilová J, Boday A, Meszarosová AU, Turnovec M, Votýpka P, Lišková P, Kremlíková Pourová R. Ann Hum Genet. 2020; 84(5):380-392.
85. Ticagrelor Added to Aspirin in Acute Ischemic Stroke or Transient Ischemic Attack in Prevention of Disabling Stroke: A Randomized Clinical Trial. Amarenco P, Denison H, Evans SR, Himmelmann A, James S, Knutsson M, Ladenvall P, Molina CA, Wang Y, Johnston SC; THALES Steering Committee and Investigators (Kurča E). JAMA Neurol. 2020; 78(2):1-9.
86. Prevalence of non-motor symptoms and their association with quality of life in cervical dystonia. Han V, Skorvanek M, Smit M, Turcanova Koprusakova M, Hoekstra T, van Dijk JP, Tijssen MAJ, Gdovinova Z, Reijneveld SA. Acta Neurol Scand. 2020; 142(6):613-622.
87. Dietary Mg2+ Intake and the Na+/Mg2+ Exchanger SLC41A1 Influence Components of Mitochondrial Energetics in Murine Cardiomyocytes. Tatarkova Z, de Baaij JHF, Grendar M, Aschenbach JR, Racay P, Bos C, Sponder G, Hoenderop JGJ, Röntgen M, Turcanova Koprusakova M, Kolisek M. Int J Mol Sci. 2020; 21(21):8221.
88. Cystic echinococcosis causing thrombosis of the inferior vena cava in a patient with multiple sclerosis treated with alemtuzumab. Kantorová E, Vajdová V, Hnilicová P, Tarčák M, Turčanová M, Kurča E, Zeleňák K. Ther Adv Neurol Disord. 2020;13:1756286420954081.
89. Current Methods of Magnetic Resonance for Noninvasive Assessment of Molecular Aspects of Pathoetiology in Multiple Sclerosis. Hnilicová P, Štrbák O, Kolisek M, Kurča E, Zeleňák K, Sivák Š, Kantorová E. Int J Mol Sci. 2020; 21(17):6117.
90. Ofatumumab versus Teriflunomide in Multiple Sclerosis. Hauser SL, Bar-Or A, Cohen JA, Comi G, Correale J, Coyle PK, Cross AH, de Seze J, Leppert D, Montalban X, Selmaj K, Wiendl H, Kerloeguen C, Willi R, Li B, Kakarieka A, Tomic D, Goodyear A, Pingili R, Häring DA, Ramanathan K, Merschhemke M, Kappos L; ASCLEPIOS I and ASCLEPIOS II Trial Groups (Kurča E). N Engl J Med. 2020; 383(6):546-557.
91. Ticagrelor and Aspirin or Aspirin Alone in Acute Ischemic Stroke or TIA. Johnston SC, Amarenco P, Denison H, Evans SR, Himmelmann A, James S, Knutsson M, Ladenvall P, Molina CA, Wang Y; THALES Investigators (Kurča E). N Engl J Med. 2020; 383(3):207-217.
92. Safety and efficacy of tolebrutinib, an oral brain-penetrant BTK inhibitor, in relapsing multiple sclerosis: a phase 2b, randomised, double-blind, placebo-controlled trial. Reich DS, Arnold DL, Vermersch P, Bar-Or A, Fox RJ, Matta A, Turner T, Wallström E, Zhang X, Mareš M, Khabirov FA, Traboulsee A; Tolebrutinib Phase 2b Study Group (Kantorová E). Lancet Neurol. 2021; 20(9):729-738.
93. Levodopa-Carbidopa Intestinal Gel Reduces Dyskinesia in Parkinson's Disease in a Randomized Trial. Freire-Alvarez E, Kurča E, Lopez Manzanares L, Pekkonen E, Spanaki C, Vanni P, Liu Y, Sánchez-Soliño O, Barbato LM. Mov Disord. 2021; 36(11):2615-2623.
94. Virtual Reality Visual Training in an Adult Patient with Anisometropic Amblyopia: Visual and Functional Magnetic Resonance Outcomes. Halicka J, Bittsansky M, Sivak S, Piñero DP, Ziak P. Vision (Basel). 2021; 5(2):22.
95. Bilateral evacuation of bilateral non-acute subdural hematomas - evaluation of postoperative outcomes and complications. Opsenak R, Snopko P, Hanko M, Benco M, Sivak S, Kolarovszk B. Bratisl Lek Listy. 2021;122(12):866-870.
96. Efficacy and Safety of Ticagrelor and Aspirin in Patients With Moderate Ischemic Stroke: An Exploratory Analysis of the THALES Randomized Clinical Trial. Wang Y, Pan Y, Li H, Amarenco P, Denison H, Evans SR, Himmelmann A, James S, Birve F, Ladenvall P, Molina CA, Johnston SC; THALES Steering Committee and Investigators (Kurča E). JAMA Neurol. 2021; 78(9):1091-1098.
97. Fatigue as the limiting factor for vaginal birth in patients with multiple sclerosis. Biringer K, Sivak S, Sivakova J, Ružiňák R, Martiníková M, Kantorova E, Biringerová Z, Kudela E, Kurca E. Neuro Endocrinol Lett. 2021; 42(4):222-228.
98. Atypical presentation of Charcot-Marie-Tooth disease type 1C with a new mutation: a case report. Turčanová Koprušáková M, Grofik M, Kantorová E, Jungová P, Chandoga J, Kolisek M, Valkovič P, Škorvánek M, Ploski R, Kurča E, Sivák Š. BMC Neurol. 2021; 21(1):293.
99. Positivity of oligoclonal bands in the cerebrospinal fluid predisposed to metabolic changes and rearrangement of inhibitory/excitatory neurotransmitters in subcortical brain structures in multiple sclerosis. Kantorová E, Hnilicová P, Bogner W, Grendár M, Čierny D, Hečková E, Strasser B, Ružinák R, Zeleňák K, Kurča E. Mult Scler Relat Disord. 2021; 52:102978.
100. LRRK2 mutations in Parkinson's disease patients from Central Europe: A case control study. Skorvanek M, Rizig M, Athanasiou-Fragkouli A, Necpal J, Straka I, Tamas G, Kurca E, Mosejova A, Han V, Lorincova T, Ostrozovicova M, Liesenerova S, Levicka P, Fajcikova L, Minar M, Valkovic P, Mákos O, Kelemen A, Grofik M, Cibulka M, Jama F, Houlden H; members of the CEGEMOD study group. Parkinsonism Relat Disord. 2021; 83:110-112.
101. Contrast-induced encephalopathy. Babalova L, Ruzinak R, Ballova J, Sivak S, Kantorova E, Kurca E, Zelenak K, Nosal V. Bratisl Lek Listy. 2021; 122(9):618-620.
102. Comparison of SARS-CoV-2 Detection by Rapid Antigen and by Three Commercial RT-qPCR Tests: A Study from Martin University Hospital in Slovakia. Dankova Z, Novakova E, Skerenova M, Holubekova V, Lucansky V, Dvorska D, Brany D, Kolkova Z, Strnadel J, Mersakova S, Janikova K, Samec M, Pokusa M, Petras M, Sarlinova M, Kasubova I, Loderer D, Sadlonova V, Kompanikova J, Kotlebova N, Kompanikova A, Hrnciarova M, Stanclova A, Antosova M, Dzian A, Nosal V, Kocan I, Murgas D, Krkoska D, Calkovska A, Halasova E. Int J Environ Res Public Health. 2021; 18(13):7037.
103. Flavonoids against the SARS-CoV-2 induced inflammatory storm. Liskova A, Samec M, Koklesova L, Samuel SM, Zhai K, Al-Ishaq RK, Abotaleb M, Nosal V, Kajo K, Ashrafizadeh M, Zarrabi A, Brockmueller A, Shakibaei M, Sabaka P, Mozos I, Ullrich D, Prosecky R, La Rocca G, Caprnda M, Büsselberg D, Rodrigo L, Kruzliak P, Kubatka P. Biomed Pharmacother. 2021; 138:111430.
104. Plasma levels of direct oral anticoagulants in atrial fibrillation patients at the time of embolic stroke: a pilot prospective multicenter study. Nosáľ V, Petrovičová A, Škorňová I, Bolek T, Dluhá J, Stančiaková L, Sivák Š, Babálová L, Hajaš G, Staško J, Kubisz P, Kurča E, Samoš M, Mokáň M. Eur J Clin Pharmacol. 2022; 78(4):557-564.
105. Effect of Pillbox Organizers with Alarms on Adherence to Pharmacotherapy in Parkinson Disease Patients Taking Three and More Daily Doses of Dopaminergic Medications. Straka I, Minar M, Grofik M, Skorvanek M, Bolekova V, Gazova A, Kyselovic J, Valkovic P. J Pers Med. 2022; 12(2):179.
106. Extensive Brain Pathologic Alterations Detected with 7.0-T MR Spectroscopic Imaging Associated with Disability in Multiple Sclerosis. Heckova E, Dal-Bianco A, Strasser B, Hangel GJ, Lipka A, Motyka S, Hingerl L, Rommer PS, Berger T, Hnilicová P, Kantorová E, Leutmezer F, Kurča E, Gruber S, Trattnig S, Bogner W. Radiology. 2022; 303(1):141-150.
107. Chronic lymphocytic inflammation with pontine perivascular enhancement responsive to steroids (CLIPPERS) syndrome: Treatment approach depends on disease course. Kovacova S, Hnilicova P, Grossmann J, Hajas G, Kantorova E, Kurca E. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2022. doi: 10.5507/bp.2022.013. Online ahead of print.
108. Proton magnetic resonance spectroscopy changes in the brainstem in patients after mild traumatic brain injury with loss of consciousness. Ruzinak R, Bittsansky M, Martinikova M, Nosal V, Kantorova E, Ballova J, Turcanova Koprusakova M, Hnilicova P, Grendar M, Dusenka R, Kolarovszki B, Zelenak K, Kurca E, Sivak S. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2022; 166(1):84-90.
109. Deep brain stimulation electrode position impact on parkinsonian non-motor symptoms. Bardon J, Kurcova S, Chudackova M, Otruba P, Krahulik D, Nevrly M, Kanovsky P, Zapletalova J, Valosek J, Hlustik P, Vastik M, Vecerkova M, Hvizdosova L, Mensikova K, Kurca E, Sivak S. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2022; 166(1):57-62.
110. Alzheimer's Disease-Associated SNP rs708727 in SLC41A1 May Increase Risk for Parkinson's Disease: Report from Enlarged Slovak Study. Cibulka M, Brodnanova M, Grendar M, Necpal J, Benetin J, Han V, Kurca E, Nosal V, Skorvanek M, Vesely B, Stanclova A, Lasabova Z, Pös Z, Szemes T, Stuchlik S, Grofik M, Kolisek M. Int J Mol Sci. 2022; 23(3):1604.
111. Neurocognitive performance in relapsing-remitting multiple sclerosis patients is associated with metabolic abnormalities of the thalamus but not the hippocampus- GABA-edited 1H MRS study. Kantorová E, Hnilicová P, Bogner W, Grendár M, Grossmann J, Kováčová S, Hečková E, Strasser B, Čierny D, Zeleňák K, Kurča E. Neurol Res. 2022; 44(1):57-64.
112. Incidence and prevalence of neuromyelitis optica spectrum disorders in Slovakia. Szilasiová J, Gazda J, Cimprichová A, Cvengrošová A, Donáth V, Fedičová M, Gurčík L, Hančinová V, Jurčaga F, Kahancová E, Kantorová E, Karlík M, Klímová E, Kováčová S, Krastev G, Megová A, Michalík J, Mikula P, Snopeková Ľ, Števková Z. Neurol Res. 2022; 44(1):38-46.
113. Alzheimer's Disease Risk Variant rs3865444 in the CD33 Gene: A Possible Role in Susceptibility to Multiple Sclerosis. Javor J, Bucová M, Ďurmanová V, Radošinská D, Párnická Z, Čierny D, Kurča E, Čopíková-Cudráková D, Gmitterová K, Shawkatová I. Life (Basel). 2022 Jul 21;12(7):1094.
114. Backward leaning during gait: An underrecognized sign in Niemann-Pick type C. Mainka T, Kurvits L, Skorvanek M, Necpal J, Grofik M, Ganos C. Parkinsonism Relat Disord. 2022 Aug;101:96-98. doi: 10.1016/j.parkreldis.2022.07.004. Epub 2022 Jul 14.
115. Information-processing speed in mildly disabled relapsing-remitting multiple sclerosis patients correlates with volumetry of optic chiasma and subcortical grey matter nuclei. Kovacova S, Hnilicova P, Cierny D, Babalova L, Grossmann J, Kurca E, Kantorova E. Bratisl Lek Listy. 2022;123(9):678-684.
116. In vitro modeling of amyotrophic lateral sclerosis with induced pluripotent stem cell technology-derived cell line ORIONi002-A. Strnadel J, Dumortier HM, Hajduchova D, Zahumenska R, Nosal V, Smolar M, Marcinek J, Kalman M, Mersakova S, Brany D, Juhas S, Juhasova J, Studenovska H, Mitruskova B, Suroviakova S, Novakova S, Skovierova H, Kurca E, Pecova R, Plank L, Halasova E. Stem Cell Res. 2022 Aug;63:102870. doi: 10.1016/j.scr.2022.102870.
117. Comparison of Restenosis Risk in Single-Layer versus Dual-Layer Carotid Stents: A Duplex Ultrasound Evaluation. Sýkora J, Zeleňák K, Vorčák M, Števík M, Sýkorová M, Sivák J, Rovňák M, Zapletalová J, Mužík J, Šinák I, Kurča E, Meyer L, Fiehler J. Cardiovasc Intervent Radiol. 2022 Sep;45(9):1257-1266.
118. Correction: A case of novel DYT6 dystonia variant with serious complications after deep brain stimulation therapy: a case report. Grofik M, Cibulka M, Olekšakova J, Turčanova Koprušakova M, Galanda T, Necpal J, Jungova P, Kurča E, Winkelmann J, Zech M, Jech R. BMC Neurol. 2022 Nov 3;22(1):407.
119. Oxidative stress parameters and their relation to motor subtype of Parkinson's disease and levodopa treatment status. Grofik M, Cibulka M, Oleksakova J, Sivak S, Cierny D, Tatarkova Z, Grendar M, Nosal V, Ruzinak R, Kurca E, Kolisek M. Gen Physiol Biophys. 2023 Jan;42(1):77-85.
120. Lesion-Specific Metabolic Alterations in Relapsing-Remitting Multiple Sclerosis Via 7 T Magnetic Resonance Spectroscopic Imaging. Lipka A, Niess E, Dal-Bianco A, Hangel GJ, Rommer PS, Strasser B, Motyka S, Hingerl L, Berger T, Hnilicová P, Kantorová E, Leutmezer F, Kurča E, Gruber S, Trattnig S, Bogner W. Invest Radiol. 2023 Feb 1;58(2):156-165.
121. Imaging Methods Applicable in the Diagnostics of Alzheimer's Disease, Considering the Involvement of Insulin Resistance. Hnilicova P, Kantorova E, Sutovsky S, Grofik M, Zelenak K, Kurca E, Zilka N, Parvanovova P, Kolisek M. Int J Mol Sci. 2023 Feb 7;24(4):3325.
122. Embolization of Ruptured Infratentorial Pial AVM in Pregnancy. Zeleňák K, Šalát D, Kolarovszki B, Kurča E, Zeleňáková J, Koçer N. Life (Basel). 2023 Mar 28;13(4):896.
123. Autonomic control of heart and vessels in patients with very early stage of Parkinson disease. Oleksakova J, Javorka M, Czippelova B, Mazgutova N, Grofik M, Babalova L, Skacik P, Kurca E. Physiol Meas. 2023 May 9;44(5). doi: 10.1088/1361-6579/accefb.
124. A high-throughput liquid chromatography-tandem mass spectrometry method for simultaneous determination of direct oral anticoagulants in human plasma. Žideková N, Pršo K, Brisudová K, Babálová L, Bolek T, Sivák Š, Kurča E, Mokrý J, Samoš M, Nosáľ V, Kertys M. J Sep Sci. 2023 Jul;46(13):e2300084. doi: 10.1002/jssc.202300084.
125. Biomedical research brings mTBI biomarkers a step closer to the bedside - implementation in clinical practice. Martinikova M, Ruzinak R, Kurca E, Grey MT, Sivak S. Gen Physiol Biophys. 2023 Jul;42(4):323-338.
126. Chronic lymphocytic inflammation with pontine perivascular enhancement responsive to steroids (CLIPPERS) syndrome: Treatment approach depends on disease course. Kovacova S, Hnilicova P, Grossmann J, Hajas G, Kantorova E, Kurca E. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2023 Sep;167(3):303-308.
127. Modelling Duchenne muscular dystrophy in vitro with newly generated, blood cell-derived induced pluripotent stem cell line ORIONi003-A. Hajduchova D, Suroviakova S, Mersakova S, Brany D, Zahumenska R, Rehak M, Skovierova H, Nováková S, Nosal V, Marcinek J, Kalman M, Jozef Pec M, Brozmanova M, Melegova J, Juhas S, Juhasova J, Studenovska H, Mitruskova B, Pokusa M, Samec M, Samos M, Nicodemou A, Danisovic L, Dankova Z, Kurca E, Lexova Kolejakova K, Chandoga J, Plank L, Halasova E, Pecova R, Strnadel J. Stem Cell Res. 2023 Sep;71:103187. doi: 10.1016/j.scr.2023.103187.
128. Analysis of Cdx2 VDR gene polymorphism rs11568820 in association with multiple sclerosis in Slovaks. Čierny D, Dobrota D, Kantorová E, Malicherová B, Škereňová M, Javor J, Kurča E, Lehotský J. Neurol Res. 2023 Oct;45(10):912-918.
129. Endovascular thrombectomy for acute ischaemic stroke with established large infarct: multicentre, open-label, randomised trial. Bendszus M, Fiehler J, Subtil F, Bonekamp S, Aamodt AH, Fuentes B, Gizewski ER, Hill MD, Krajina A, Pierot L, Simonsen CZ, Zeleňák K, Blauenfeldt RA, Cheng B, Denis A, Deutschmann H, Dorn F, Flottmann F, Gellißen S, Gerber JC, Goyal M, Haring J, Herweh C, Hopf-Jensen S, Hua VT, Jensen M, Kastrup A, Keil CF, Klepanec A, Kurča E, Mikkelsen R, Möhlenbruch M, Müller-Hülsbeck S, Münnich N, Pagano P, Papanagiotou P, Petzold GC, Pham M, Puetz V, Raupach J, Reimann G, Ringleb PA, Schell M, Schlemm E, Schönenberger S, Tennøe B, Ulfert C, Vališ K, Vítková E, Vollherbst DF, Wick W, Thomalla G; TENSION Investigators. Lancet. 2023 Nov 11;402(10414):1753-1763.
130. Acute polyneuropathy: a serious complication of levodopa/ /carbidopa intestinal gel treatment for Parkinson's Disease. Havránková P, Roth J, Čapek V, Klempíř J, Baláž M, Rektorová I, Haň V, Skorvanek M, Gmitterová K, Minár M, Valkovič P, Kaiserová M, Kaňovský P, Grofik M, Kurča E, Necpál J, Jech R. Neurol Neurochir Pol. 2024;58(6):586-592.
131. Secondary complications of vestibular neuropathy. Skacik P, Sivak S, Kurca E. Bratisl Lek Listy. 2024;125(12):802-806.
132. Predictors of Outcome after Direct Aspiration of Basilar Artery Occlusion. Mako M, Krastev G, Nosáľ V, Haring J, Jakubcová D, Daniš M, Klepanec A, Haršány J, Sivák Š, Kurča E. J Clin Med. 2024 Mar 9;13(6):1576.
133. Central European Group on Genetics of Movement Disorders. Ostrozovicova M, Dusek P, Grofik M, Han V, Holly P, Jech R, Klivenyi P, Kovacs N, Kulcsarova K, Kurca E, Lackova A, Magocova V, Necpal J, Pinter D, Ruzicka E, Serranova T, Smilowska K, Straka I, Svorenova T, Tamas G, Valkovic P, Zarubova K, Houlden H, Rizig M, Skorvanek M. Eur J Neurol. 2024 Apr;31(4):e16165. doi: 10.1111/ene.16165.
134. Dyskinesia and Pain in Advanced Parkinson's Disease: Post Hoc Analysis from the Phase 3b, Open-Label, Randomized DYSCOVER Study. Freire-Alvarez E, Vanni P, Kurča E, Lopez-Manzanares L, Kovács N, Spanaki C, Gao T, Bergmann L, Sánchez-Soliño O. Neurol Ther. 2024 Apr;13(2):437-447.
135. p.L1795F LRRK2 variant is a common cause of Parkinson's disease in Central Europe. Ostrozovicova M, Tamas G, Dušek P, Grofik M, Han V, Holly P, Jech R, Kalinova K, Klivenyi P, Kovacs N, Kulcsarova K, Kurca E, Lackova A, Lee H, Lewis P, Magocova V, Marekova M, Murphy D, Necpal J, Pinter D, Rabajdova M, Růžička E, Serranova T, Smilowska K, Soos K, Straka I, Svorenova T, Valkovic P, Zarubova K, Gdovinova Z, Houlden H, Rizig M, Skorvanek M. Res Sq [Preprint]. 2024 May 29:rs.3.rs-4378197. doi: 10.21203/rs.3.rs-4378197/v1.
136. Disturbances in Muscle Energy Metabolism in Patients with Amyotrophic Lateral Sclerosis. Parvanovova P, Hnilicova P, Kolisek M, Tatarkova Z, Halasova E, Kurca E, Holubcikova S, Koprusakova MT, Baranovicova E. Metabolites. 2024 Jun 23;14(7):356.
137. The Role of Magnesium in Parkinson's Disease: Status Quo and Implications for Future Research. Cibulka M, Brodnanova M, Halasova E, Kurca E, Kolisek M, Grofik M. Int J Mol Sci. 2024 Aug 1;25(15):8425.
138. Brain of miyoshi myopathy/dysferlinopathy patients presents with structural and metabolic anomalies. Hnilicova P, Grendar M, Turcanova Koprusakova M, Trancikova Kralova A, Harsanyiova J, Krssak M, Just I, Misovicova N, Hikkelova M, Grossmann J, Spalek P, Meciarova I, Kurca E, Zilka N, Zelenak K, Bogner W, Kolisek M. Sci Rep. 2024 Aug 20;14(1):19267. doi: 10.1038/s41598-024-69966-4.
139. Endovascular thrombectomy for acute ischaemic stroke with established large infarct (TENSION): 12-month outcomes of a multicentre, open-label, randomised trial. Thomalla G, Fiehler J, Subtil F, Bonekamp S, Aamodt AH, Fuentes B, Gizewski ER, Hill MD, Krajina A, Pierot L, Simonsen CZ, Zeleňák K, Blauenfeldt RA, Cheng B, Denis A, Deutschmann H, Dorn F, Flottmann F, Gellißen S, Gerber JC, Goyal M, Haring J, Herweh C, Hopf-Jensen S, Hua VT, Jensen M, Kastrup A, Keil CF, Klepanec A, Kurča E, Mikkelsen R, Möhlenbruch M, Müller-Hülsbeck S, Münnich N, Pagano P, Papanagiotou P, Petzold GC, Pham M, Puetz V, Raupach J, Reimann G, Ringleb PA, Schell M, Schlemm E, Schönenberger S, Tennøe B, Ulfert C, Vališ K, Vítková E, Vollherbst DF, Wick W, Bendszus M; TENSION Investigators. Lancet Neurol. 2024 Sep;23(9):883-892.
140. Forecasting extremely high ischemic stroke incidence using meteorological time serie. Babalova L, Grendar M, Kurca E, Sivak S, Kantorova E, Mikulova K, Stastny P, Fasko P, Szaboova K, Kubatka P, Nosal S, Mikulik R, Nosal V. PLoS One. 2024 Sep 11;19(9):e0310018. doi: 10.1371/journal.pone.0310018.
141. Identification of alemtuzumab-suitable multiple sclerosis patients in Slovakia and sequencing of post-alemtuzumab immunomodulatory treatment. Kantorová E, Vítková M, Martiníková M, Cimprichová A, Fedicˇová M, Kovácˇová S, Mako M, Cisár J, Hancˇinová V, Szilasiová J, Koleda P, RoháIˇová J, Polóniová J, Karlík M, Slezáková D, Klímová E, Maciak M, Kurcˇa E, Hnilicová P. Ther Adv Neurol Disord. 2024 Oct 28;17:17562864241285556. doi: 10.1177/17562864241285556.
142. Safety and efficacy of simple training protocol in patients after mild traumatic brain injury. Martinikova M, Ruzinak R, Hnilicova P, Bittsansky M, Grendar M, Babalova L, Skacik P, Kantorova E, Nosal V, Turcanova Koprusakova M, Sivak J, Sivakova J, Biringerova Z, Kolarovszki B, Zelenak K, Kurca E, Sivak S. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2024 Nov;168(4):295-303.
143. Gastrointestinal Complications of Mitochondrial Encephalomyopathy, Lactic Acidosis and Stroke-Like Episodes (MELAS) Syndrome Managed By Parenteral Nutrition. Horná S, Péč MJ, Krivuš J, Michalová R, Sivák Š, Galajda P, Mokáň M. Eur J Case Rep Intern Med. 2024 Jan 22;11(2):004268. doi: 10.12890/2024_004268. eCollection 2024.
144. Clinical and demographic characteristics of patients with NMOSD: a longitudinal retrospective analysis of a Slovak cohort of 63 patients. Szilasiová J, Gazda J, Mikula P, Cvengrošová A, Fedičová M, Hančinová V, Kantorová E, Karlík M, Kováčová S. Neurol Sci. 2024 Feb;45(2):693-698. doi: 10.1007/s10072-023-07050-x. Epub 2023 Sep 12.
145. Exploring CJD incidence trends: insights from Slovakia. Skacik P, Kurca E, Sivak S. Prion. 2024 Dec;18(1):87-88.
146. Mitochondrial Dysfunction in Sporadic Amyotrophic Lateral Sclerosis Patients: Insights from High-Resolution Respirometry. Parvanovova P, Evinova A, Grofik M, Hnilicova P, Tatarkova Z, Turcanova-Koprusakova M. Biomedicines. 2024 Jun 11;12(6):1294. doi: 10.3390/biomedicines12061294.
147. Screening for diabetic peripheral neuropathy at community pharmacies in Slovakia. Pagáčová Z, Grofik M, Fazekaš T, Žufková V, Mináriková D. Croat Med J. 2024 Apr 30;65(2):85-92. doi: 10.3325/cmj.2024.65.85.
148. Arterial Collaterals and Endovascular Treatment Effect in Acute Ischemic Stroke with Large Infarct: A Secondary Analysis of the TENSION Trial. Winkelmeier L, Kniep H, Thomalla G, Bendszus M, Subtil F, Bonekamp S, Aamodt AH, Fuentes B, Gizewski ER, Hill MD, Krajina A, Pierot L, Simonsen CZ, Zeleňák K, Blauenfeldt RA, Cheng B, Denis A, Deutschmann H, Dorn F, Gellissen S, Gerber JC, Goyal M, Haring J, Herweh C, Hopf-Jensen S, Hua VT, Jensen M, Kastrup A, Keil CF, Klepanec A, Kurča E, Mikkelsen R, Möhlenbruch M, Müller-Hülsbeck S, Münnich N, Pagano P, Papanagiotou P, Petzold GC, Pham M, Puetz V, Raupach J, Reimann G, Ringleb PA, Schell M, Schlemm E, Schönenberger S, Tennøe B, Ulfert C, Vališ K, Vítková E, Vollherbst DF, Wick W, Fiehler J, Flottmann F; TENSION Investigators. Radiology. 2025 Feb;314(2):e242401. doi: 10.1148/radiol.242401.
149. Negative Video Head Impulse Test in Acute Vestibular Syndrome Does Not Exclude Vestibular Neuritis: Insights and Challenges in Diagnosis. Skacik P, Sivak S, Kurca E. Clin Case Rep. 2025 Mar 16;13(3):e70300. doi: 10.1002/ccr3.70300.
150. Prevalence and Clinical Characteristics of the LRRK2 p.L1795F Variant in Central Europeans with Early-Onset and Familial Parkinson's Disease. Ostrozovicova M, Tamas G, Atputhavadivel A, Dusek P, Grofik M, Han V, Holly P, Jech R, Kalinova K, Klivenyi P, Kovacs N, Kulcsarova K, Kurca E, Lackova A, Lee H, Lewis P, Magocova V, Marekova M, Murphy D, Nagano A, Necpal J, Pinter D, Rabajdova M, Ruzicka E, Serranova T, Smilowska K, Soos K, Straka I, Svorenova T, Valkovic P, Zarubova K, Gdovinova Z, Houlden H, Rizig M, Skorvanek M; CEGEMOD consortium. Mov Disord Clin Pract. 2025 Mar 22. doi: 10.1002/mdc3.70045.
151. Thrombectomy With Low ASPECTS: The Roles of Infarct Volume and Postacute Neurological Status. Kniep H, Gellißen S, Thomalla G, Bendszus M, Winkelmeier L, Broocks G, Bechstein M, Subtil F, Bonekamp S, Aamodt AH, Fuentes B, Gizewski ER, Hill MD, Krajina A, Pierot L, Simonsen CZ, Zeleňák K, Blauenfeldt RA, Cheng B, Denis A, Deutschmann H, Dorn F, Flottmann F, Gerber JC, Goyal M, Haring J, Herweh C, Hopf-Jensen S, Hua VT, Jensen M, Kastrup A, Keil CF, Klepanec A, Kurča E, Mikkelsen R, Möhlenbruch M, Müller-Hülsbeck S, Münnich N, Pagano P, Papanagiotou P, Petzold GC, Pham M, Puetz V, Raupach J, Reimann G, Ringleb PA, Schell M, Schlemm E, Schönenberger S, Tennøe B, Ulfert C, Vališ K, Vítková E, Vollherbst DF, Wick W, Fiehler J, Meyer L; TENSION Investigators. Stroke. 2025 Mar 25. doi: 10.1161/STROKEAHA.124.050052.
152. ABCB1 gene single nucleotide variants and haplotypes in atrial fibrillation patients experiencing adverse events on direct oral anticoagulation: a whole gene exome sequencing study. Samoš M, Škereňová M, Nosáľ V, Škorňová I, Bolek T, Grendár M, Kamenišťáková A, Šarlinová M, Petrovičová A, Jurica J, Stančiaková L, Péč M, Halašová E, Kurča E, Sokol J, Staško J, Mokáň M. J Cardiovasc Pharmacol. 2025 Mar 28. doi: 10.1097/FJC.0000000000001695.
153. The prediction model of academic achievement based on cardiorespiratory fitness and BMI status for ninth-grade students. Bielik V, Nosáľ V, Nechalová L, Špánik M, Žilková K, Grendar M. BMC Pediatr. 2025 Jan 9;25(1):20. doi: 10.1186/s12887-024-05353-2.